U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07337174) titled 'Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects' on Dec. 22, 2025.
Brief Summary: The trial uses a randomized, open-label, single-dose administration per period, and a 2 x 2 crossover design where subjects receive both treatments sequentially with a washout.
Study Start Date: Jan. 25
Study Type: INTERVENTIONAL
Condition:
Obesity
Intervention:
DRUG: HUC2-676
subcutaneous injection
DRUG: HUC2-676-R
subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Huons Co., Ltd.
Published by HT Digital Content Services with ...